Rion Aesthetics to present at IMCAS, and showcase the innovative, breakthrough, and highly effective nature of platelet-derived extract

“At Rion Aesthetics, we are committed to setting a new standard in regenerative aesthetics with our Renewosome™ technology, which is at the forefront of this field.”

— ALISA LASK, MBA, CEO OF RION AESTHETICS

ROCHESTER, Minn.--(BUSINESS WIRE)--RION AESTHETICS, a leading company in the field of regenerative aesthetics, is thrilled to announce its participation in IMCAS, the premier congress for the latest evidence-based techniques and developments in dermatology, plastic surgery, and regenerative aesthetics. The congress will be held in Paris from January 26 to 28, 2023.

Atta Behfar, M.D., Ph.D., founder of Rion, Inc., will be presenting the six-week data from the Platelets on Skin Health (POSH) study at IMCAS. The presentation, entitled "Efficacy and Tolerability of Topical Platelet Exosomes for Skin Rejuvenation: Six-Week Results" will showcase the innovative and highly effective platelet-derived extract for cosmetic applications. Sponsored by RION AESTHETICS, the study evaluated ( plated )™ Skin Science INTENSE Serum and the data was recently published in the June 2022 edition of Aesthetic Surgery Journal.

"We are thrilled to attend IMCAS and share our groundbreaking scientific discovery with the world," said Alisa Lask, MBA, CEO of Rion Aesthetics. "At Rion Aesthetics, we are committed to setting a new standard in regenerative aesthetics with our Renewosome™ technology, which is at the forefront of this field."

The study demonstrated that ( plated )™ achieved statistically significant results across a multitude of skin-aging indicators as early as 6 weeks—including improvements in the appearance of redness, brown spots, wrinkles, color evenness, and overall luminosity. "We are continuing to pursue cosmetic and aesthetic uses for our proprietary technology, bringing forward our vision of leading the transformation of aesthetics to regenerative technologies," said Lask.

For more information, please visit www.platedskinscience.com.

Reference: Wyles SP. Efficacy and Tolerability of Topical Platelet Exosomes for Skin Rejuvenation. Six-Week Results. Aesthetic Surgery Journal. 2022 Jun. PMID: 35689936.

About ( plated )™ Skin Science

( plated )™ is a cosmetic product, designed to promote beautification and reduce the appearance of a host of cosmetic skin challenges. ( plated)™ is not an FDA approved drug and is not intended to treat, cure, or prevent any condition or disease.

For more information, please talk to your aesthetics provider or visit www.rionaesthetics.com.

To report an adverse reaction, please contact RION AESTHETICS at info@platedskinscience.com.

About RION AESTHETICS

RION AESTHETICS is a regenerative aesthetics company, pioneering the use of platelet-derived exosomes for skincare and restorative clinical applications. Backed by 15 years of visionary science, we aim to transform skincare through the launch of ( plated )™ Skin Science, a scientific breakthrough leveraging Human Platelet Extract, a proprietary ingredient full of antioxidants and growth factors that help to rejuvenate skin. Beyond skincare, RION AESTHETICS is also developing the first room-temperature off-the-shelf regenerative exosomes for FDA applications to address unmet needs in applications such as hair loss and facial wrinkles.

Follow us on social media @RionAesthetics
Instagram: https://www.instagram.com/rionaesthetics
LinkedIn: https://www.linkedin.com/company/rion-aesthetics

Related Links
https://www.rionaesthetics.com/

Contacts

Jodi Brichan, jbrichan@rionax.com